FDA Approved: DOBUTAMINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for the dobutamine product from Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure

Drugs mentioned

• Dobutamine (dobutamine)

Snippet

SUPPL AP for DOBUTAMINE (DOBUTAMINE)